federation Highland eat colon cancer cea level prognosis trigger Plenary session do homework
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Colon Cancer: Symptoms, Stages & Treatment
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer
CEA concentration in supernatant of different colon cancer cell lines | Download Table
JCM | Free Full-Text | Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer
Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer - Prager - 2014 - Cancer Science - Wiley Online Library
Rectal Cancer Workup: Laboratory Studies, Screening for Colon and Rectal Cancer, Histologic Findings
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
Long-term survival of patients with stage III colon cancer treated with VRP- CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio | Journal for ImmunoTherapy of Cancer
Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India | JCO Global Oncology
Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system - Chen - 2014 - Cancer - Wiley Online Library
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status | PLOS ONE
Overall survival of 387 patients with metastatic colorectal cancer... | Download Scientific Diagram
Colon Cancer Treatment (PDQ®) - NCI
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open
High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer | World Journal of Surgical Oncology | Full Text
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort | Annals of Surgical Oncology
KoreaMed Synapse
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer - Winesh Ramphal, Jeske R.E. Boeding, Maartje van Iwaarden, Jennifer M.J. Schreinemakers, Harm J.T. Rutten, Rogier M.P.H. Crolla,
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer - ScienceDirect
Survival curves of patients with stage III colon cancer according to... | Download Scientific Diagram
Frontiers | Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer